EGIS and Appomart Update Neuroscanner

EGIS, headquartered in Budapest, Hungary, is one of the leaders in the pharmaceutical market. With over seventy years of experience in the healthcare sector, EGIS is known for developing medications for the treatment of depression, anxiety disorders, cognitive impairments, and other psychoneurological diseases. The company produces well-known drugs such as venlafaxine, escitalopram, paroxetine, sertraline, fluvoxamine, buspirone, imipramine, pregabalin, clomipramine, quetiapine, donepezil, memantine, lorazepam, tofisopam, hydroxyzine, etifoxine, risperidone, aripiprazole, amitriptyline, and many others. Our collaboration began a year ago, and during this period, the Appomart team has carried out several updates to the Neuroscanner app. The recent update marked another significant milestone in our partnership, demonstrating our commitment to integrating advanced technologies and up-to-date solutions.

What"s new in Neuroscanner

The update to the Neuroscanner app was undertaken with the aim of enhancing analytical capabilities, user interaction, and audience expansion.

A key objective was the implementation of analytics, a tool that provides more precise and detailed data on user behavior. Now, the company can better understand how users interact with the app and make informed decisions to improve their experience.

Additionally, the Neuroscanner has integrated a popular cloud solution for managing push notifications. Push notifications play a critically important role in maintaining user engagement and informing them about new features or updates. The implementation of this technology ensures more prompt and targeted interaction with users, which is expected to enhance their satisfaction and loyalty.

To increase the visibility and appeal of the app in app stores, work was carried out within the framework of App Store Optimization (ASO). We optimized the metadata and textual descriptions of Neuroscanner to improve the app"s ranking in search results on the App Store and Google Play. This will attract new users and increase the overall number of app downloads.

The Neuroscanner update, performed by the Appomart team, includes important improvements that will help EGIS better understand its users, increase their engagement, and attract a new audience. The implementation of analytics tools and push notification management technologies and the work on ASO create a solid foundation for the app"s future development. These steps are aimed not only at enhancing functionality and visibility but are also strategically important decisions for market success and competitiveness.

Any company that hasn"t yet approached the question of strategically updating its applications should seriously consider these steps. EGIS"s experience in this process is exemplary. Their initiative to improve Neuroscanner demonstrates the importance of well-founded and strategically significant decisions aimed at long-term development and competitiveness.

If your business seeks similar achievements, the Appomart team is ready to help you accomplish similar goals. Contact us to discuss how we can become your reliable partner in app development and optimization.